Gordion Bioscience
Outsmarting cancer with tumor data and machine learning
Poznan, Poland · Founded 2023 · $120K raised
- Headquarters
- Poznan
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- gordion.bio
- Total Funding
- $120K
- Last Round
- $120K SeedJan 2023
About
Gordion Bioscience is a biotech company developing better cancer drugs by uniquely integrating patient selection into the target identification stage. Using real patient tumor whole genome data — including both exome and dark genome alterations — Gordion identifies novel drug targets that are invisible in cell line-based assays. Their machine learning platform combines cohort selection with target identification into a single coherent strategy, enabling more precise and effective oncology drug development.
Summary
Gordion Bioscience is a Healthcare company based in Poznan, Poland, founded in 2023. It has raised $120K in total, most recently a $120K Seed round in Jan 2023.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe